Hot search: Pep  automotive  price  Logistics  goods  foreign  Trade  consumer  Safety  Economy 
 
Home > News > Market > Content

Edgemont Pharmaceuticals Launched a Formulation Dose of Bupropion Extended-Release Tablets

increase font size  reduce font Add date: 2016-11-30  Hits:44
Core prompt: Edgemont Pharmaceuticals has launched a new formulation dose of bupropion extended-release tablets in a strength of 450mg dose.

Edgemont Pharmaceuticals has launched a new formulation dose of bupropion extended-release tablets in a strength of 450mg dose.

The Forfivo XL, which the company claims, is the only available 450mg dose of an extended-release bupropion product and is intended for the treatment of major depressive disorder (MDD).

Edgemont Pharmaceuticals president and CEO Douglas Saltel said until now, most patients in the US requiring a 450mg dose of bupropion have been taking multiple tablets to achieve their dose requirement.

"We are very pleased to be able to simplify the dosing regimen for these patients to a single Forfivo XL 450mg tablet once-daily," Saltel added.

The company said Bupropion Hcl is marketed under several dosage forms and brand names including Wellbutrin, Wellbutrin SR and Wellbutrin XL.

 

 

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed